Not much new here in last three years. The Chemo is clouding the data. Oh well.
I see John is still hyping antisense drugs after failing for over 15 years in his guidance. Be careful here folks... this one is over priced... way over priced at $14. I've called Isis right on point for approx two decades. Nope, not a short, just doing my good deed. Wish you all luck, also, with your Vical shares. Vical is a better buy... much better ! Take care.